Coming Soon
Find comprehensive information on Dry Eye Syndrome (DES), also known as Keratoconjunctivitis Sicca or simply Dry Eyes. This resource offers guidance on diagnosis, clinical documentation, and medical coding for Dry Eye Disease, including ICD-10 codes and ocular surface disease management. Learn about the signs, symptoms, and treatment options for dry eyes, essential for healthcare professionals and patients seeking accurate information.
Also known as
Keratoconjunctivitis sicca
Dry eye syndrome due to deficient tear production.
Other keratoconjunctivitis
Includes unspecified and other forms of keratoconjunctivitis.
Diseases of the eye and adnexa
Encompasses various eye conditions including dry eye related disorders.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the dry eye syndrome due to Sjogren's disease?
When to use each related code
| Description |
|---|
| Dry eyes, insufficient lubrication. |
| Inflammation of eyelid margin. |
| Inflammation of conjunctiva. |
Coding dry eye without specifying severity (mild, moderate, severe) can lead to underpayment and inaccurate quality reporting. Use H04.12x.
Failure to document and code associated conditions like Sjogren's syndrome (M35.0) or blepharitis (H01.0) impacts reimbursement and care plans.
Incorrectly coding dry eye as unilateral when it's bilateral (or vice-versa) affects medical necessity for certain procedures and treatments.
Q: What are the most effective diagnostic tests for differentiating aqueous deficient dry eye from evaporative dry eye in clinical practice?
A: Accurately differentiating aqueous deficient dry eye (ADDE) from evaporative dry eye (EDE) is crucial for targeted treatment. Schirmer's test, while a common initial screening tool, primarily assesses aqueous tear production and may not fully capture EDE. Tear breakup time (TBUT) is more indicative of tear film stability and thus helps identify EDE. However, both tests have limitations. More advanced diagnostics like meibography assess meibomian gland morphology and function, providing valuable insights into EDE. Lipid layer interferometry can evaluate tear film lipid layer thickness, further aiding in EDE diagnosis. Osmolarity testing reflects tear film stability and is useful for both ADDE and EDE assessment. Consider implementing a combination of these tests for a comprehensive evaluation and explore how tear film osmolarity can enhance diagnostic accuracy. Learn more about the latest diagnostic criteria for dry eye syndrome published by TFOS DEWS II.
Q: How can I manage dry eye syndrome in patients with concurrent systemic autoimmune diseases like Sjogren's syndrome or rheumatoid arthritis?
A: Managing dry eye syndrome in patients with systemic autoimmune diseases like Sjogren's syndrome or rheumatoid arthritis requires a multifaceted approach. These conditions often exacerbate dry eye due to underlying inflammatory processes. Beyond artificial tears, consider implementing immunomodulatory therapies like cyclosporine or lifitegrast for patients with moderate to severe dry eye associated with inflammation. Punctal plugs can improve tear retention, while warm compresses and lid hygiene address meibomian gland dysfunction, commonly seen in these patients. Careful assessment and management of the underlying systemic disease are essential. Explore how systemic immunosuppressants, when appropriate for the underlying autoimmune condition, can indirectly benefit ocular surface health. Always consider the patient's overall health status and potential drug interactions when developing a treatment plan. Learn more about the interplay of systemic autoimmune disease and dry eye in recent research publications.
Patient presents with complaints consistent with dry eye syndrome (DES), also known as keratoconjunctivitis sicca. Symptoms include ocular dryness, burning, grittiness, foreign body sensation, and intermittent blurry vision. Patient reports increased discomfort in low-humidity environments, during prolonged visual tasks such as computer use, and after extended contact lens wear. Ocular examination reveals mild conjunctival injection, decreased tear film break-up time (TBUT), and corneal fluorescein staining consistent with superficial punctate keratitis. Schirmer's test results indicate reduced tear production. Assessment supports a diagnosis of dry eye syndrome. The patient was educated on the chronic nature of dry eye disease and the importance of consistent management. Treatment plan includes artificial tears for symptomatic relief, recommended use of a humidifier, warm compresses, and eyelid hygiene with lid scrubs. Patient advised to limit contact lens wear and take frequent breaks during visually demanding activities. Follow-up scheduled in four weeks to reassess symptoms and adjust treatment as needed. ICD-10 code H04.121 for dry eye syndrome, moderate severity, will be used for billing purposes. Differential diagnoses considered include blepharitis and allergic conjunctivitis, which were ruled out based on clinical findings. Patient understands and agrees with the proposed treatment plan.